• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Lee Schwartzberg, MD, FACP: Nurse Education on Biosimilars


Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the need for practice-wide education concerning biosimilars in cancer care.


There has to be a practice-wide campaign for everyone in the care chain to understand biosimilars. So, when it comes to infusion nurses, they understand they're giving a different drug, but it's in the same class. And so, when we're changing drugs, we get an informed consent for these patients so they know it's a new drug. When we're starting new, the infusion nurses are just hanging them just like any other drug.

Related Videos
Jeffrey Casberg, RPh, MS.
Adam Colborn, JD.
Legal scale weighs profit as greater than medical treatment
Ha Kung Wong, JD.
Ha Kung Wong, JD
Cencora's Corey Ford
Brian Biehn
Chelsee Jensen, PharmD, BCPS
Ryan Haumschild, PharmD, MS, MBA
Related Content
© 2024 MJH Life Sciences

All rights reserved.